| Literature DB >> 25095784 |
Teresa K Schuessler1, Xin Yi Chan2, Huanhuan Joyce Chen3, Kyungmin Ji4, Kyung Min Park2, Alireza Roshan-Ghias5, Pallavi Sethi6, Archana Thakur7, Xi Tian8, Aranzazu Villasante5, Ioannis K Zervantonakis9, Nicole M Moore1, Larry A Nagahara1, Nastaran Z Kuhn10.
Abstract
Advanced technologies and biomaterials developed for tissue engineering and regenerative medicine present tractable biomimetic systems with potential applications for cancer research. Recently, the National Cancer Institute convened a Strategic Workshop to explore the use of tissue biomanufacturing for development of dynamic, physiologically relevant in vitro and ex vivo biomimetic systems to study cancer biology and drug efficacy. The workshop provided a forum to identify current progress, research gaps, and necessary steps to advance the field. Opportunities discussed included development of tumor biomimetic systems with an emphasis on reproducibility and validation of new biomimetic tumor models, as described in this report. ©2014 American Association for Cancer Research.Entities:
Mesh:
Year: 2014 PMID: 25095784 PMCID: PMC4184963 DOI: 10.1158/0008-5472.CAN-14-1706
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701